Application | Comment | Organism |
---|---|---|
medicine | potential of succinyl phosphonate esters for modeling the biochemical and pathophysiological consequences of reduced KGDHC activity in brain diseases | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-oxo-4-phosphonobutanoic acid | affects (1-13C)glucose and (U-13C)glutamate metabolism, phosphonoethyl and carboxy ethyl ester reduce the concentration of aspartate, alanine and gamma-aminobutyric acid, phosphonoethyl ester reduces gluthatione content, carboxy ethyl ester reduces the intracellular concentration of valine and leucine | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Mus musculus | - |
cerebellum | - |
Mus musculus | - |
neuron | cerebellar granule neurons | Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | KGDHC is an important component of the tricarboxylic acid cycle | Mus musculus | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
alpha-ketoglutarate dehydrogenase | - |
Mus musculus |
alpha-ketoglutarate dehydrogenase complex | - |
Mus musculus |
E1k | - |
Mus musculus |
KGDHC | - |
Mus musculus |